Hamza Suria has sold ANAB and made no open-market buys since Dec 2018
President and CEO at AnaptysBio, Inc.
SEC CIK 0001654495 · Filings on SEC.gov ↗
$0Bought
$15.7MSold
NoneLast buy
Every filing
8 filings since Dec 2018, newest first
ANABSell
Anaptysbio, Inc
President and CEO
$1.3M−35.0%Dec 22
ANABSell
Anaptysbio, Inc
President and CEO
$713K−23.0%Nov 5
ANABSell
Anaptysbio, Inc
President and CEO
$1.2M−35.0%Nov 2
ANABSell
Anaptysbio, Inc
President and CEO
$480K−19.0%Oct 28
ANABSell
Anaptysbio Inc
President and CEO
$1.7M−56.0%Jun 12
ANABSell
Anaptysbio Inc
President and CEO
$2.8M−57.0%Jan 16
ANABSell
Anaptysbio Inc
President and CEO
$2.9M−58.0%Dec 18
ANABSell
Anaptysbio Inc
President and CEO
$4.7M−69.0%Dec 12
Filings come from SEC EDGAR. Not investment advice.